Researchers looked at lung tissue from 28 COPD patients and 15 smokers who underwent surgery for suspected or confirmed lung ...

Prevalence of chronic obstructive pulmonary disease (COPD) and the disease's burden varies significantly by state.

COPD has a large economic impact on the healthcare system and a destructive impact on the lives of patients and their ...

The FDA recently approved mepolizumab for treating adults with inadequately controlled COPD and an eosinophilic phenotype, ...

It is becoming increasingly recognized that people with COPD have an elevated risk of serious CV events,1 discussed Hanania ...

The study followed 351 patients across four Korean hospitals who had received anti-tuberculosis treatment for more than six months. These individuals were monitored over 11 years (132 months) to ...

Researchers discover an unusual accumulation of particles in people with the disease; the causes are still unclear.

Quantitative CT textures may provide imaging evidence of the spatial heterogeneity of lung inflammation and disease burden in COPD.

Pliant Therapeutics has terminated its idiopathic pulmonary fibrosis (IPF) program after digging into the increased rate of ...

Yoga can be a valuable complement to pulmonary therapy for chronic respiratory diseases, such as COPD and asthma. By ...

Chinese scientists have developed a novel nanotherapy known as biomimetic extracellular vesicle spherical nucleic acids ...

The secrets of idiopathic pulmonary fibrosis (IPF) are written in its very name. Idiopathic refers to a disease of unknown ...